ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $48.00 to $50.00. They now have an "overweight" rating on the stock.
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by BTIG Research. They now have a $73.00 price target on the stock.
Oruka Therapeutics (ORKA) had its price target raised by Stifel Nicolaus from $47.00 to $72.00. They now have a "buy" rating on the stock.
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Form S-8 Oruka Therapeutics, Inc.
Form 10-K Oruka Therapeutics, Inc. For: Dec 31
Form 4 Oruka Therapeutics, Inc. For: Mar 02 Filed by: Sandler Laura Lee
Form 4 Oruka Therapeutics, Inc. For: Feb 17 Filed by: Goncalves Joana
Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.